Evidence map›Paper›PMID 32495493›Full record

ArticleObesity (Silver Spring, Md.)2020

COVID-19: A Lever for the Recognition of Obesity as a Disease? The French Experience.

Karine Clément, Muriel Coupaye, Martine Laville, Jean-Michel Oppert, Olivier Ziegler

Abstract readComment
In one paragraph

Article in Obesity (Silver Spring, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.Clinics and research in hepatology and gastroenterology · 2022
    Review
  3. Review
  4. Emergencies in obese patients: a narrative review.Journal of anesthesia, analgesia and critical care · 2021
    Review
  5. Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity Societies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
    Review
  6. Review
  7. COVID-19 and Obesity: Dangerous Liaisons.Journal of clinical medicine · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Karine ClémentAssistance-Publique-Hôpitaux de Paris, Nutrition Department, Pitié-Salpêtrière hospital, Sorbonne University, Paris, France.ORCID https://orcid.org/0000-0002-2489-3355
Muriel CoupayeAssistance-Publique-Hôpitaux de Paris, Nutrition Department, Pitié-Salpêtrière hospital, Sorbonne University, Paris, France.
Martine LavilleHospices Civils de Lyon, Département Endocrinologie, Diabète et Nutrition, Centre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, F-CRIN/FORCE Network, Pierre Bénite, Lyon, France.
Jean-Michel OppertAssistance-Publique-Hôpitaux de Paris, Nutrition Department, Pitié-Salpêtrière hospital, Sorbonne University, Paris, France.
Olivier ZieglerSpecialized Obesity Center and Endocrinology, Diabetology, Nutrition dept, Brabois Hospital, CHRU of Nancy, F-CRIN/FORCE Network, Vandoeuvre-Les-Nancy, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralRespiration, ArtificialSevere Acute Respiratory SyndromeBetacoronavirusCOVID-19HumansObesityPrevalenceSARS-CoV-2

Identifiers

PMID32495493
PMCPMC7300927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.